Kara Firas M, Doty Stephen B, Boskey Adele, Goldring Steven, Zaidi Mone, Fredholm Bertil B, Cronstein Bruce N
New York University School of Medicine, New York, NY, USA.
Arthritis Rheum. 2010 Feb;62(2):534-41. doi: 10.1002/art.27219.
Accelerated osteoclastic bone resorption plays a central role in the pathogenesis of osteoporosis and other bone diseases. Because identifying the molecular pathways that regulate osteoclast activity provides a key to understanding the causes of these diseases and developing new treatments, we studied the effect of adenosine A(1) receptor blockade or deletion on bone density.
The bone mineral density (BMD) in adenosine A(1) receptor-knockout (A(1)R-knockout) mice was analyzed by dual x-ray absorptiometry (DXA) scanning, and the trabecular and cortical bone volume was determined by microfocal computed tomography (micro-CT). The mice were ovariectomized or sham-operated, and 5 weeks after surgery, when osteopenia had developed, several parameters were analyzed by DXA scanning and micro-CT. A histologic examination of bones obtained from A(1)R-knockout and wild-type mice was carried out. Visualization of osteoblast function (bone formation) after tetracycline double-labeling was performed by fluorescence microscopy.
Micro-CT analysis of bones from A(1)R-knockout mice showed significantly increased bone volume. Electron microscopy of bones from A(1)R-knockout mice showed the absence of ruffled borders of osteoclasts and osteoclast bone resorption. Immunohistologic analysis demonstrated that although osteoclasts were present in the A(1)R-knockout mice, they were smaller and often not associated with bone. No morphologic changes in osteoblasts were observed, and bone-labeling studies revealed no change in the bone formation rates in A(1)R-knockout mice.
These results suggest that the adenosine A(1) receptor may be a useful target in treating diseases characterized by excessive bone turnover, such as osteoporosis and prosthetic joint loosening.
破骨细胞介导的骨吸收加速在骨质疏松症和其他骨疾病的发病机制中起核心作用。由于确定调节破骨细胞活性的分子途径是理解这些疾病病因和开发新治疗方法的关键,我们研究了腺苷A(1)受体阻断或缺失对骨密度的影响。
采用双能X线吸收法(DXA)扫描分析腺苷A(1)受体基因敲除(A(1)R基因敲除)小鼠的骨矿物质密度(BMD),并用微焦点计算机断层扫描(micro-CT)测定小梁骨和皮质骨体积。对小鼠进行卵巢切除或假手术,术后5周,当骨质减少出现时,通过DXA扫描和micro-CT分析多个参数。对A(1)R基因敲除和野生型小鼠的骨骼进行组织学检查。通过荧光显微镜观察四环素双重标记后成骨细胞功能(骨形成)的可视化情况。
对A(1)R基因敲除小鼠骨骼的micro-CT分析显示骨体积显著增加。对A(1)R基因敲除小鼠骨骼的电子显微镜检查显示破骨细胞没有褶皱边缘且无破骨细胞骨吸收。免疫组织学分析表明,尽管A(1)R基因敲除小鼠中有破骨细胞存在,但它们较小且通常不与骨组织相连。未观察到成骨细胞的形态学变化,骨标记研究显示A(1)R基因敲除小鼠的骨形成率没有变化。
这些结果表明,腺苷A(1)受体可能是治疗以骨转换过度为特征的疾病(如骨质疏松症和人工关节松动)的有用靶点。